Vimal Patel © 2022 The New York Times Company

Vimal Patel © 2022 The New York Times Company

Opinions/Stories

A Covid pill from Merck showed more promise in reducing the risk of hospitalisation

A study last year by Merck, which developed the pill with the help of Ridgeback Biotherapeutics, found that the drug reduced the risk of hospitalisation by 30%

via The New York Times
Read Article